Cargando…
New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword?
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810207/ https://www.ncbi.nlm.nih.gov/pubmed/35112193 http://dx.doi.org/10.1007/s10067-021-06041-7 |
_version_ | 1784644202509893632 |
---|---|
author | Anzola, Ana M. Trives, Laura Martínez-Barrio, Julia Pinilla, Blanca Álvaro-Gracia, José María Molina-Collada, Juan |
author_facet | Anzola, Ana M. Trives, Laura Martínez-Barrio, Julia Pinilla, Blanca Álvaro-Gracia, José María Molina-Collada, Juan |
author_sort | Anzola, Ana M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8810207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-88102072022-02-03 New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword? Anzola, Ana M. Trives, Laura Martínez-Barrio, Julia Pinilla, Blanca Álvaro-Gracia, José María Molina-Collada, Juan Clin Rheumatol Letter to the Editor Springer International Publishing 2022-02-03 2022 /pmc/articles/PMC8810207/ /pubmed/35112193 http://dx.doi.org/10.1007/s10067-021-06041-7 Text en © International League of Associations for Rheumatology (ILAR) 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Letter to the Editor Anzola, Ana M. Trives, Laura Martínez-Barrio, Julia Pinilla, Blanca Álvaro-Gracia, José María Molina-Collada, Juan New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword? |
title | New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword? |
title_full | New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword? |
title_fullStr | New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword? |
title_full_unstemmed | New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword? |
title_short | New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword? |
title_sort | new-onset giant cell arteritis following covid-19 mrna (biontech/pfizer) vaccine: a double-edged sword? |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810207/ https://www.ncbi.nlm.nih.gov/pubmed/35112193 http://dx.doi.org/10.1007/s10067-021-06041-7 |
work_keys_str_mv | AT anzolaanam newonsetgiantcellarteritisfollowingcovid19mrnabiontechpfizervaccineadoubleedgedsword AT triveslaura newonsetgiantcellarteritisfollowingcovid19mrnabiontechpfizervaccineadoubleedgedsword AT martinezbarriojulia newonsetgiantcellarteritisfollowingcovid19mrnabiontechpfizervaccineadoubleedgedsword AT pinillablanca newonsetgiantcellarteritisfollowingcovid19mrnabiontechpfizervaccineadoubleedgedsword AT alvarograciajosemaria newonsetgiantcellarteritisfollowingcovid19mrnabiontechpfizervaccineadoubleedgedsword AT molinacolladajuan newonsetgiantcellarteritisfollowingcovid19mrnabiontechpfizervaccineadoubleedgedsword |